Cure My Disease

Don't miss your cure!

 Log in / Sign up

AI as a coach for caregivers: a new test of support and strength

NCT ID NCT07799389

Symptom relief Sponsor: Kastamonu University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 02, 2026 · Last updated Sep 03, 2026 · Updated 1 time

Summary

This trial tests a six-week, nurse-led support program for people caring for a loved one in palliative care. The program uses generative AI to tailor guidance on stress, coping, and self-care, with nurses supervising the content. Researchers will compare caregivers who receive this program with those getting routine care to see if it improves their readiness to care and their psychological resilience.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
A six-week nurse-led psychosocial support program that uses generative AI as a supervised tool to personalize guidance for caregivers.
What this could lead to
If effective, this program could offer a practical way to help family caregivers feel more prepared and emotionally strong while caring for a loved one in palliative care.
What could go wrong
The trial is small and early, so results may not apply to all caregivers. The AI tool is new and requires careful oversight, and the program's success depends on how well it fits each person's needs.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 88 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Oct 2026

An estimate. Start dates often move.

Expected to finish

Mar 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Aged 18 years or older. Being the primary caregiver of a patient receiving palliative care. Providing unpaid caregiving. Being able to read, understand, and communicate in Turkish. Having sufficient cognitive and communication abilities to complete the data collection instruments. Being able to use the generative AI-supported program with the explanation and technical support provided by the researcher, when necessary. Voluntarily agreeing to participate in the six-week intervention program and providing written informed consent. Exclusion Criteria: -Not being the primary caregiver of the palliative care patient. Providing caregiving services for payment. Having cognitive, visual, auditory, or communication difficulties that prevent understanding the data collection instruments or using the program despite the support provided. Concurrently participating in another structured psychoeducational or psychosocial support program for caregivers. Not having the capacity to participate in the study or provide informed consent. \-

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Primary caregiver readiness for care and psychological resilience in palliative care are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Primary caregiver readiness for care and psychological resilience in palliative care

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  2. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.